The double-blind variable placebo lead-in period: results from two antidepressant clinical trials / Douglas E. Faries en Journal of Clinical Psychopharmacology, Año 2001 - Vol. 21 - No. 6 (Diciembre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 6 (Diciembre) . - pp. 561-568 Título : The double-blind variable placebo lead-in period: results from two antidepressant clinical trials Tipo de documento: texto impreso Autores: Douglas E. Faries, Autor ; John H. Heiligenstein, Autor ; Gary D. Tollefson, Autor Fecha de publicación: 2023 Artículo en la página: pp. 561-568 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Ensayos clínicos, Trastorno depresivo mayor, Ensayos controlados aleatorios Resumen: The 1-week single-blind placebo lead-in has long been a standard in double-blind psychopharmacology clinical trials. Although a lead-in period is often necessary (e.g., to receive laboratory results before randomization), some authors have demonstrated that the standard single-blind placebo lead-in’s performance was similar to having a lead-in in which placebo was not administered. Link: ./index.php?lvl=notice_display&id=31101 [artículo] The double-blind variable placebo lead-in period: results from two antidepressant clinical trials [texto impreso] / Douglas E. Faries, Autor ; John H. Heiligenstein, Autor ; Gary D. Tollefson, Autor . - 2023 . - pp. 561-568. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 6 (Diciembre) . - pp. 561-568 Palabras clave: Antidepresivos, Ensayos clínicos, Trastorno depresivo mayor, Ensayos controlados aleatorios Resumen: The 1-week single-blind placebo lead-in has long been a standard in double-blind psychopharmacology clinical trials. Although a lead-in period is often necessary (e.g., to receive laboratory results before randomization), some authors have demonstrated that the standard single-blind placebo lead-in’s performance was similar to having a lead-in in which placebo was not administered. Link: ./index.php?lvl=notice_display&id=31101

---

1 (1 - 1 / 1)